In contrast, frequent HMX2 expression was detected in 13/42 (31.0%) AML patients with KMT2A-rearrangements (GSE19577), demonstrating high incidence in this tumor subtype (S1D Fig). Here, HMX2 is linked to acute myeloid leukemia.